Definition of Terms
The following terms are used in A.S.P.E.N. documents approved by the Board of Directors:
Administer: The act of delivering substance(s) to an individual by a prescribed dosage and route.
Administration: The physical delivery of substance(s) to individuals.
Admixture: The result of combining 2 or more fluids.
Adolescent: 11 years to 21 years of age. 11 Adverse Event: An adverse event is any undesirable experience associated with the use of a medical product in a patient. The adverse event is serious when the patient outcome is: death, life-threatening, hospitalization (initial or prolonged), disability or permanent damage, congenital anomaly / birth defect, required intervention to prevent permanent impairment or damage (devices) or other serious outcomes (important medical events). 12 Automated Compounding Device: A device that compounds parenteral preparations. When relating to parenteral nutrition, it transfers large-volume parenterals such as dextrose, amino acids, fat emulsion, and sterile water, as well as small-volume parenterals including electrolytes, minerals, and vitamins to the final parenteral nutrition container. (adapted from Safe Practices for Parenteral Nutrition 3 )
Beyond-Use Date:
• (parenteral): The date or time after which a compounded sterile preparation shall not be stored or transported. The date is determined from the date or time the preparation is compounded.
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• (enteral): The date established by healthcare professionals recommended in the published literature or manufacturer-specific recommendations beyond which the facility-prepared product should not be used. This definition also includes closed enteral feeding systems that do not require facility preparation, but for which the manufacturer's expiration date is no longer valid once the product is spiked with an enteral administration set. (adapted from Enteral Nutrition Practice Recommendations 5 )
Birth Weight: First weight of the fetus or newborn obtained after birth.
14
• Low Birth Weight: weight of less than 2500 g (up to and including 2499 g).
• Very Low Birth Weight: weight of less than 1500 g.
• Extremely Low Birth Weight: weight of less than 1000 g.
Body Weight: [see Weight]
Calorie: In metabolic studies, the Calorie (equivalent to 1000 calories or 1 kilocalorie [kcal] ) is the amount of heat energy required to raise or lower 1 kg of pure liquid water by 1°C. The Calorie is used in nutrition to express the energy content of food. 15 Calorie should only be used in the quantification of energy.
[also see Energy]
Care Plan: Design (or scheme) of professional clinical activities developed to implement and achieve treatment goals.
Child: 12 months to 11 years of age.
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Closed Enteral System: A closed enteral container pre-filled with sterile, liquid formula by the manufacturer which is considered ready to hang. 16 Compatibility: The ability to combine 2 or more products such that the physical integrity and stability of each product is not altered when combined. By contrast, incompatibility refers to the physical alteration of a product when combined with 1 or more other products as a result of concentration or temperaturedependent reactions (e.g., precipitation) that can alter activity or stability. Diet: A prescribed allowance of food or nutrients provided via the oral route.
• Regular Diet or Normal Diet: A full, well-balanced diet containing all of the essential nutrients needed for optimal growth, tissue repair, and normal functioning of the organs. Such a diet contains foods rich in proteins, carbohydrates, high-quality fats, minerals, and vitamins in proportions that meet the specific nutrient requirements of the individual.(adapted from Mosby's Medical Dictionary, 8th ed. Regular diet.
)
• Enteral Access Device: Tube placed directly into the gastrointestinal tract for the delivery of nutrients and/or drugs.
Enteral Misconnection: An inadvertent connection between an enteral feeding system and a non-enteral system such as an intravascular line, peritoneal dialysis catheter, tracheostomy, medical gas tubing, etc.
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Enteral Nutrition: Feeding provided through the gastrointestinal tract via a tube, catheter, or stoma that delivers nutrients distal to the oral cavity. Enteral nutrition to be used in preference to "enteral feeding".
Expiration Date:
• (foods): "Generally, 'expiration' dates and 'use-by' dates are the last dates that the manufacturer recommends a food item be consumed to ensure peak quality and nutrient retention. However, there is no regulation requiring that manufacturers mark their product with such dates. The one exception to these general rules is infant formula. The Food and Drug Administration (FDA) requires manufacturers mark infant formula with a 'use-by' date. Additionally, the FDA prohibits the sale of infant formula after the use-by date."
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• (drugs): Identifies the time during which the drug product may be expected to meet the requirements of the compendial monograph, provided it is kept under the prescribed storage conditions; limits the time during which the article may be dispensed or used. Where an expiration date is stated only in terms of the month and year, it is a representation that the intended expiration date is the last day of the stated month. (adapted from United States Pharmacopeia. General Notices and Requirements 24 )
Geriatric: An adult 65 years of age or greater. 25 Hang Time (for enteral nutrition): The length of time a formulation is considered safe for administration to the patient beginning with the time the formulation has been compounded, reconstituted, warmed, decanted, or has had the original package seal broken. (adapted from Enteral Nutrition Practice Recommendations
)
Indicators: Prospectively-determined measures used as normative standards within a performance improvement process.
Infant: Birth to 12 months of age.
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Intravenous Fat Emulsion: An intravenous oil-in-water emulsion of oils(s), egg phosphatides, and glycerin. The term should be used in preference to lipids.
Malnutrition: An acute, subacute or chronic state of nutrition, in which a combination of varying degrees of overnutrition or undernutrition with or without inflammatory activity have led to a change in body composition and diminished function. (adapted from Soeters PB, Schols AM. Advances in understanding and assessing malnutrition 26 )
The 3 etiology-based nutrition diagnoses in adults in clinical practice settings are:
• Starvation-related malnutrition: chronic starvation without inflammation (e.g., anorexia nervosa)
• Chronic disease-related malnutrition: inflammation is chronic and of mild to moderate degree (e.g., organ failure, pancreatic cancer, rheumatoid arthritis or sarcopenic obesity) • Acute disease or injury-related malnutrition: inflammation is acute and of severe degree (e.g., major infection, burns, trauma or closed head injury) 27 Medical Food: "…a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation" 28 as defined in section 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3)).
Medical Nutrition Therapy:
• Two phases of (a) assessment of the nutrition status of the patient or client, and (b) treatment which includes diet therapy, counseling, or use of specialized nutrition supplements. Nutrition: The sum of processes by which one takes in and utilizes nutrients.
• Nutrition vs. Nutritional:
o Nutrition: Of or relating to the state of nutrition or things related to the field of nutrition. Can be used as a compound structure with terms such as nutrition support, nutrition nurse, nutrition team, nutrition program, etc.
o Nutritional: Usually that which has nutrient value, such as nutritional cereal, nutritional meal, and so on.
Nutrition Assessment: A comprehensive approach to diagnosing nutrition problems that uses a combination of the following: medical, nutrition, and medication histories; physical examination; anthropometric measurements; and laboratory data.
Nutritionally-at-Risk Neonates: Neonates should be considered at nutrition risk if they have any of the following:
• Low birth weight (<2500 g) even in the absence of gastrointestinal, pulmonary, or cardiac disorders.
34
• Birth weight greater than 2 standard deviations below the mean (approximately the 3rd percentile) for gestational age on fetal weight curves.
• Acute weight loss of 10% or more.
Nutritionally-at-Risk Children: Children should be considered at nutrition risk if they have any of the following:
• A weight for length or weight for height or sex less than the 10th percentile or greater than the 95th percentile.
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• Body mass index for age or sex less than 5th percentile or greater than the 85th percentile.
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• Increased metabolic requirements.
29
• Impaired ability to ingest or tolerate oral feedings.
• Documented inadequate provision of or tolerance of nutrients.
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• Inadequate weight gain or a significant decrease in usual growth percentile. 31 Nutritionally-at-Risk Adults: Adults may be considered at nutrition risk if they have any of the following:
• Involuntary loss of ≥10% of usual body weight within 6 months, or involuntary loss of ≥5% of usual body weight in 1 month.
36
• Involuntary loss or gain of 10 pounds within 6 months.
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• Body mass index less than 18.5 kg/m 2 or greater than 25 kg/m 2 .
38
• Chronic disease.
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• Altered diets or diet schedules.
• Inadequate nutrition intake, including not receiving food or nutrition products for greater than 7 days. 39 Nutrition Care: Interventions, monitoring, and evaluation designed to facilitate appropriate nutrient intake based upon the integration of information from the nutrition assessment.
Nutrition Care Plan: A formal statement of the nutrition goals and interventions prescribed for an individual using the data obtained from a nutrition assessment. The plan should include statements of nutrition goals and monitoring/evaluation parameters, the most appropriate route of administration of nutrition therapy, method of nutrition access, anticipated duration of therapy, and training and counseling goals and methods.
Nutrition Screening: A process to identify an individual who may be malnourished or at risk for malnutrition to determine if a detailed nutrition assessment is indicated. Outcome: The measured result of the performance of a system or process.
Oral Nutrition: Nutrients taken by mouth.
Parenteral Nutrition: The intravenous administration of nutrients. (Parenteral nutrition to be used in preference to "parenteral feeding".)
• Central: Parenteral nutrition delivered into a large-diameter vein, usually the superior vena cava adjacent to the right atrium.
• Peripheral: Parenteral nutrition delivered into a peripheral vein, usually of the hand or forearm.
3 Pediatrics: Includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence when the growth and developmental processes are generally completed. The responsibility of pediatrics therefore may begin during pregnancy and usually terminates by 21 years of age.
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Pharmacodynamics: The study of the biological effects resulting from the interaction between drugs and biological systems. Pharmacokinetics: The study of the absorption, distribution, metabolism, and elimination of drugs in patients. Sentinel Event: An unexpected occurrence involving death or serious physical or psychological injury, or the risk thereof. Serious injury specifically includes loss of limb or function. The phrase "or the risk thereof" includes any process variation for which a recurrence would carry a significant chance of a serious adverse outcome. 44 Stability: The extent to which a product retains, within specified limits and throughout its period of storage and use (i.e., its shelf-life), the same properties and characteristics that it possessed at the time of its preparation. 45 Standardized, Commercial Parenteral Nutrition Product: A standardized parenteral nutrition formulation available from a manufacturer and requiring fewer compounding steps before administration. Current examples of these products are concentrated amino acids (with or without electrolytes) plus concentrated dextrose containers or multichamber bags of these products, often called premixed solutions.
Standardized Parenteral Nutrition Formulation: A parenteral nutrition formulation intended to meet the daily maintenance requirements of a specific patient population (e.g., age-, stress-, or disease state-specific) and differentiated by route of administration (central vs. peripheral vein). 4 Total Nutrient Admixture: A parenteral nutrition formulation containing intravenous fat emulsion as well as the other components of parenteral nutrition (dextrose, amino acids, vitamins, minerals, water, and other additives) in a single container. 2. Place a space between the numerical value and unit symbols (e.g., 25 mg, never 25mg). 46, 47 3. Do not use trailing zeros for integers (e.g., 5 mg, never 5.0 mg). 47, 48 Exception: A "trailing zero" may be used only where required to demonstrate the level of precision of the value being reported, such as for laboratory results, imaging studies that report size of lesions, or catheter/tube sizes. 48 4. Always use leading zeros for numerical values less than 1 (e.g., 0.3, never .3). 47, 48 Exception: certain statistical values such as α levels or P values, should be reported without the use of 0 before the decimal marker. 49 5. Unit symbols are unaltered in the plural (e.g., 175 cm, never 175 cms). 46 6. Unit symbols are not followed by a period unless at the end of a sentence (e.g., 175 cm, never 175 cm.). 46, 47 7. Information is not mixed with unit symbols or names (e.g., "the water content is 20 mL/kg" never "20 mL H2O/kg" or "20 mL of water/kg"). 46 8. Express drug products by generic name (use lowercase letters) as the primary drug nomenclature, ensuring that each matches Food and Drug Administration (FDA) or United States Pharmacopeia (USP)-approved nomenclature. Do not abbreviate drug names. 47 Do not use slang or stem names (e.g., "intravenous fat emulsion" is preferred to "lipids").
9. Do not use proprietary, commercial trade names unless both of the following criteria are met: 1) Use of the trade name is essential for the reader to distinguish among similar products for clinical or research purposes, and 2) Specific evidence is provided to document or contrast the use of one product vs. another similar product. If a trade name is used, begin the trade name with a capital letter and include the appropriate legal symbol (e.g., ©, ®, or ™).
10. Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention unless the abbreviation is a standard unit of measurement. recommend that mcg be used to avoid confusion with mg. a The mu (μ) symbol is acceptable in the scientific literature; however, ISMP 47 and The Joint Commission 48 recommend that μ not be used as μg (e.g., mcg should be used to avoid confusion with mg. See Table 4 ). 
49

